Simplified criteria for the diagnosis of autoimmune hepatitis

Diagnosis of autoimmune hepatitis (AIH) may be challenging. However, early diagnosis is important because immunosuppression is life‐saving. Diagnostic criteria of the International Autoimmune Hepatitis Group (IAIHG) were complex and purely meant for scientific purposes. This study of the IAIHG aims to define simplified diagnostic criteria for routine clinical practice. Candidate criteria included sex, age, autoantibodies, immunoglobulins, absence of viral hepatitis, and histology. The training set included 250 AIH patients and 193 controls from 11 centers worldwide. Scores were built from variables showing predictive ability in univariate analysis. Diagnostic value of each score was assessed by the area under the receiver operating characteristic (ROC) curve. The best score was validated using data of an additional 109 AIH patients and 284 controls. This score included autoantibodies, immunoglobulin G, histology, and exclusion of viral hepatitis. The area under the curve for prediction of AIH was 0.946 in the training set and 0.91 in the validation set. Based on the ROC curves, two cutoff points were chosen. The score was found to have 88% sensitivity and 97% specificity (cutoff ≥6) and 81% sensitivity and 99% specificity (cutoff ≥7) in the validation set. Conclusion: A reliable diagnosis of AIH can be made using a very simple diagnostic score. We propose the diagnosis of probable AIH at a cutoff point greater than 6 points and definite AIH 7 points or higher. (HEPATOLOGY 2008.)

[1]  A. Lohse,et al.  The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders , 2007, Journal of autoimmune diseases.

[2]  P. Galle,et al.  Evaluation of F-Actin ELISA for the Diagnosis of Autoimmune Hepatitis , 2006, The American Journal of Gastroenterology.

[3]  B. Portmann,et al.  Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. , 2006, Journal of hepatology.

[4]  T. Arenovich,et al.  Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome , 2005, Hepatology.

[5]  E. Ballot,et al.  Diagnostic Value of Anti‐F‐Actin Antibodies in a French Multicenter Study , 2005, Annals of the New York Academy of Sciences.

[6]  M. Swain,et al.  A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful? , 2005, American journal of hematology.

[7]  M. Manns,et al.  Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. , 2004, Journal of hepatology.

[8]  P. Galle,et al.  Liver Assessment and Biopsy in Patients With Marked Coagulopathy: Value of Mini-Laparoscopy and Control of Bleeding , 2003, American Journal of Gastroenterology.

[9]  J. Herkel,et al.  Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics , 2002, Gut.

[10]  P. Schirmacher,et al.  Autoimmune hepatitis and overlap syndromes. , 2002, Clinics in liver disease.

[11]  Mark George Thomas,et al.  Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease , 2002, Hepatology.

[12]  J. Herkel,et al.  Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas , 2002, Hepatology.

[13]  G. Gerken,et al.  Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. , 2001, Zeitschrift fur Gastroenterologie.

[14]  T. Kanematsu,et al.  Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group. , 2000, Internal medicine.

[15]  K. Lindor,et al.  Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. , 2000, Journal of hepatology.

[16]  F. Vleggaar,et al.  High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. , 2000, Journal of hepatology.

[17]  J. Herkel,et al.  Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis , 2000, The Lancet.

[18]  M. Manns,et al.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.

[19]  E. Elias,et al.  Recurrence of autoimmune hepatitis after liver transplantation. , 1999, Transplantation.

[20]  D. R. Parker,et al.  Autoimmune hepatitis in the elderly , 1998, Gut.

[21]  G. Gerken,et al.  Autoimmune hepatitis and hepatitis C virus infection. , 1998, Current studies in hematology and blood transfusion.

[22]  K. Kikuchi,et al.  Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis , 1997, Journal of Gastroenterology.

[23]  M. Omata,et al.  Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. , 1997, Journal of hepatology.

[24]  M. Gaffey,et al.  The international autoimmune hepatitis score in chronic hepatitis C , 1997, Journal of viral hepatitis.

[25]  A. Czaja,et al.  Validation of scoring system for diagnosis of autoimmune hepatitis , 1996, Digestive Diseases and Sciences.

[26]  G. Gerken,et al.  Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. , 1995, Zeitschrift fur Gastroenterologie.

[27]  P. Johnson,et al.  Meeting report: International autoimmune hepatitis group , 1993, Hepatology.

[28]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[29]  S. Pocock,et al.  Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. , 1980, Gut.

[30]  L. Elveback,et al.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.

[31]  F. Giostra,et al.  Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis , 2005, Digestive Diseases and Sciences.

[32]  K. Boberg,et al.  Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. , 1998, Scandinavian journal of gastroenterology.

[33]  N. Mcintyre,et al.  A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. , 1993, Journal of hepatology.